- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 15.78M sh |
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 15.57M sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $293.95M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $304.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $106.73M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $111.26M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $113.69M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $119.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $311.5M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $316.99M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $419.47M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $435.97M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $228.32M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $308.6M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 14.59M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $75K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$59.76M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$4.94 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$4.94 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $32.76M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $26.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$72.11M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$75.03M |
| Revenue | Q1 2025 · Mar 31, 2024 | $59.52M |